A Pilot Study for Return of Individual Pharmacogenomic Results to Population-Based Cohort Study Participants

INTRODUCTION: Pharmacogenomic (PGx) testing results provide valuable information on drug selection and appropriate dosing, maximization of efficacy, and minimization of adverse effects. Although the number of large-scale, next-generation-sequencing-based PGx studies has recently increased, little is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohneda, Kinuko, Hiratsuka, Masahiro, Kawame, Hiroshi, Nagami, Fuji, Suzuki, Yoichi, Suzuki, Kichiya, Uruno, Akira, Sakurai-Yageta, Mika, Hamanaka, Yohei, Taira, Makiko, Ogishima, Soichi, Kuriyama, Shinichi, Hozawa, Atsushi, Tomita, Hiroaki, Minegishi, Naoko, Sugawara, Junichi, Danjoh, Inaho, Nakamura, Tomohiro, Kobayashi, Tomoko, Yamaguchi-Kabata, Yumi, Tadaka, Shu, Obara, Taku, Hishimuma, Eiji, Mano, Nariyasu, Matsuura, Masaki, Sato, Yuji, Nakasone, Masateru, Honkura, Yohei, Suzuki, Jun, Katori, Yukio, Kakuta, Yoichi, Masamune, Atsushi, Aoki, Yoko, Nakayama, Masaharu, Kure, Shigeo, Kinoshita, Kengo, Fuse, Nobuo, Yamamoto, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Medical Association 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090545/
https://www.ncbi.nlm.nih.gov/pubmed/35611229
http://dx.doi.org/10.31662/jmaj.2021-0156

Ejemplares similares

Ejemplares similares